Professional Documents
Culture Documents
Urinary Incontinece
Urinary Incontinece
Urinary Incontinece
4. calcium-channel blockers.
• Intradetrusor injection of Botulinum toxin and sacral neuromodulation are highly effective second-line
treatments for detrusor overactivity.
Mixed incontinence.
• Management.
• No single therapy works for everyone;
• Treatment depends on predominant symptoms.
Functional incontinence
• mostly older women
• urinary storage and emptying functions are intact but the patient is unable to get to the toilet on time,
whether physically OR psychologically.
• History.
• Inability to toilet oneself in a timely fashion.
• Loss of urine can vary, from small leakages to full emptying of the bladder.
• Examination.
• Varies with individual but the bladder support and innervation are intact.
• Investigative studies.
• Urinalysis and cystometry will be unremarkable & no Involuntary detrusor contractions.
• Management.
• bladder training and pelvic floor exercises (Kegel exercises).
overflow (hypotonic) incontinence
• A rise in bladder pressure occurs gradually from an
overdistended, hypotonic bladder.
• When the bladder pressure exceeds the urethral pressure,
involuntary urine loss occurs.
• Caused by:
• Denervated bladder ( Diabetic neuropathy, multiple
sclerosis).
• Systemic medications (Ganglionic blockers, anticholinergics).
• History.
• Loss of urine occurs intermittently in small amounts.
• occur in both day and night.
• The patient may complain of pelvic fullness.
• Examination.
• Pelvic examination may show normal anatomy.
• Neurologic examination: decreased pudendal nerve sensation .
• Investigative studies.
• Urinalysis and culture are usually normal, but may show an infection.
• Cystometric studies show:
1. Markedly increased residual volume.
2. Detrusor muscle not contracted Involuntary
• Management.